The immunosuppressive potential of human amniotic membrane extract

Detalhes bibliográficos
Autor(a) principal: Duque, Marta
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/15498
Resumo: Both mesenchymal stromal cells (MSCs) and human amniotic membrane (hAM) possess immunoregulatory potential, driving several studies to focus on their application in the prevention and treatment of immunological disorders, and especially on their ability to modulate T cell responses. However there is little information regarding the concrete effects over different activation and differentiation stages of T cells. The main objective of this study was to determine whether or not a hAM extract (hAME) had a differential effect over different T cell subpopulations (CD4+ and CD8+ T naïve, central memory, effector memory and effector cells). Thus, peripheral blood mononuclear cells (PBMC) were cultured in the presence or absence of hAME and stimulated with phorbol myristate acetate (PMA) plus ionomycin. Cell proliferation was evaluated through a thymidine incorporation assay and the percentages of pro-inflammatory cytokine producing T cells were determined by flow cytometry. The phenotype of hAM-derived cells was also assessed by flow cytometry. Plus, the mRNA expression of selected genes was evaluated in purified CD4+ and CD8+ T cells, regulatory T cells (Treg) and γδ T cells. The hAM-derived cells contained hAM epithelial cells and MSCs. The extract displayed an antiproliferative effect and reduced the frequency of tumor necrosis factor-alpha (TNFα), interferon gamma (IFNγ), and interleukin-2 (IL-2) producing cells, within all T cell subsets. The hAME also diminished the frequency of IL-17 and IL-9 producing T cells. The pattern of inhibition varied between CD4+ and CD8+ T cells, between T cell subsets, and depending on the cytokine under study. The hAME also produced a decrease in mRNA expression of granzime B, perforin and activating receptor NKG2D by CD8+ T cells, γδ T cells as well as an upregulation of Foxp3 and IL-10 gene expression in CD4+ T cells and an upregulation of IL-10 mRNA expression in Treg cells. These results show that the hAME differentially regulates different T cell subsets and therefore the effect of the hAME over T cells responses will depend on the T cell subpopulations involved. Still, the hAME has an overall antiinflammatory action.
id RCAP_946e51859b4b5ad1fa04b224c06f343d
oai_identifier_str oai:ria.ua.pt:10773/15498
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The immunosuppressive potential of human amniotic membrane extractBioquímicaBioquímica clínicaImunologiaMembrana amnióticaLinfócitosCelulasBoth mesenchymal stromal cells (MSCs) and human amniotic membrane (hAM) possess immunoregulatory potential, driving several studies to focus on their application in the prevention and treatment of immunological disorders, and especially on their ability to modulate T cell responses. However there is little information regarding the concrete effects over different activation and differentiation stages of T cells. The main objective of this study was to determine whether or not a hAM extract (hAME) had a differential effect over different T cell subpopulations (CD4+ and CD8+ T naïve, central memory, effector memory and effector cells). Thus, peripheral blood mononuclear cells (PBMC) were cultured in the presence or absence of hAME and stimulated with phorbol myristate acetate (PMA) plus ionomycin. Cell proliferation was evaluated through a thymidine incorporation assay and the percentages of pro-inflammatory cytokine producing T cells were determined by flow cytometry. The phenotype of hAM-derived cells was also assessed by flow cytometry. Plus, the mRNA expression of selected genes was evaluated in purified CD4+ and CD8+ T cells, regulatory T cells (Treg) and γδ T cells. The hAM-derived cells contained hAM epithelial cells and MSCs. The extract displayed an antiproliferative effect and reduced the frequency of tumor necrosis factor-alpha (TNFα), interferon gamma (IFNγ), and interleukin-2 (IL-2) producing cells, within all T cell subsets. The hAME also diminished the frequency of IL-17 and IL-9 producing T cells. The pattern of inhibition varied between CD4+ and CD8+ T cells, between T cell subsets, and depending on the cytokine under study. The hAME also produced a decrease in mRNA expression of granzime B, perforin and activating receptor NKG2D by CD8+ T cells, γδ T cells as well as an upregulation of Foxp3 and IL-10 gene expression in CD4+ T cells and an upregulation of IL-10 mRNA expression in Treg cells. These results show that the hAME differentially regulates different T cell subsets and therefore the effect of the hAME over T cells responses will depend on the T cell subpopulations involved. Still, the hAME has an overall antiinflammatory action.Tanto as células mesenquimais do estroma (MSCs) como a membrana amniótica humana (hAM) possuem capacidade imunoreguladora, levando a que vários estudos se debrucem sobre a sua aplicação na prevenção e tratamento de doenças imunológicas, e especialmente sobre a sua capacidade de modular células T. No entanto, há pouca informação acerca dos efeitos concretos sobre diferentes fases de ativação e diferenciação de células T. O principal objetivo deste estudo foi determinar se um extrato de hAM (hAME) exerce efeito diferencial sobre diferentes subpopulações de células T (células T CD4+ e CD8+ naïve, memória central, memória efetoras e efetoras). Para esse efeito, células mononucleares do sangue periférico (PBMC) foram cultivadas na presença ou ausência de hAME e estimuladas com acetato miristato de forbol (PMA) mais ionomicina. A proliferação celular foi avaliada por um ensaio de incorporação de timidina e as percentagens de linfócitos T produtores de citocinas pró-inflamatórias foram determinadas por citometria de fluxo. O fenótipo de células derivadas de hAM foi também determinado por citometria de fluxo. Foi ainda estudada a expressão de mRNA em células T CD4+ e CD8+, células T reguladoras (Treg) e células T γδ purificadas. As células derivadas de hAM continham células epiteliais e MSCs. O extrato exibiu um efeito anti-proliferativo e reduziu a frequência de células produtoras de fator de necrose tumoral alfa (TNFα), interferão gama (IFNγ), e interleucina-2 (IL-2) em todas as subpopulações de células T estudadas, assim como a frequência de células T produtoras de IL-17 e IL-9. O padrão de inibição variou entre células T CD4+ e CD8+, entre cada subpopulação celular, e dependendo da citocina em estudo. O hAME provovou também diminuição da expressão de mRNA de granzima B, perforina e recetor de ativação NKG2D em células T CD8+e células T γδ, assim como o aumento de expressão de Foxp3 e IL-10 em células T CD4+, e aumento de expressão IL-10 em células Treg. O hAME regula diferencialmente diferentes subpopulações de células T e, portanto, o efeito do hAME sobre respostas de células T será dependente das subpopulações de células T envolvidas, ainda assim, hAME tem uma ação global anti-inflamatória.Universidade de Aveiro2018-07-20T14:00:53Z2015-11-26T00:00:00Z2015-11-262017-11-19T14:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/15498engDuque, Martainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:28:41Zoai:ria.ua.pt:10773/15498Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:50:52.428374Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The immunosuppressive potential of human amniotic membrane extract
title The immunosuppressive potential of human amniotic membrane extract
spellingShingle The immunosuppressive potential of human amniotic membrane extract
Duque, Marta
Bioquímica
Bioquímica clínica
Imunologia
Membrana amniótica
Linfócitos
Celulas
title_short The immunosuppressive potential of human amniotic membrane extract
title_full The immunosuppressive potential of human amniotic membrane extract
title_fullStr The immunosuppressive potential of human amniotic membrane extract
title_full_unstemmed The immunosuppressive potential of human amniotic membrane extract
title_sort The immunosuppressive potential of human amniotic membrane extract
author Duque, Marta
author_facet Duque, Marta
author_role author
dc.contributor.author.fl_str_mv Duque, Marta
dc.subject.por.fl_str_mv Bioquímica
Bioquímica clínica
Imunologia
Membrana amniótica
Linfócitos
Celulas
topic Bioquímica
Bioquímica clínica
Imunologia
Membrana amniótica
Linfócitos
Celulas
description Both mesenchymal stromal cells (MSCs) and human amniotic membrane (hAM) possess immunoregulatory potential, driving several studies to focus on their application in the prevention and treatment of immunological disorders, and especially on their ability to modulate T cell responses. However there is little information regarding the concrete effects over different activation and differentiation stages of T cells. The main objective of this study was to determine whether or not a hAM extract (hAME) had a differential effect over different T cell subpopulations (CD4+ and CD8+ T naïve, central memory, effector memory and effector cells). Thus, peripheral blood mononuclear cells (PBMC) were cultured in the presence or absence of hAME and stimulated with phorbol myristate acetate (PMA) plus ionomycin. Cell proliferation was evaluated through a thymidine incorporation assay and the percentages of pro-inflammatory cytokine producing T cells were determined by flow cytometry. The phenotype of hAM-derived cells was also assessed by flow cytometry. Plus, the mRNA expression of selected genes was evaluated in purified CD4+ and CD8+ T cells, regulatory T cells (Treg) and γδ T cells. The hAM-derived cells contained hAM epithelial cells and MSCs. The extract displayed an antiproliferative effect and reduced the frequency of tumor necrosis factor-alpha (TNFα), interferon gamma (IFNγ), and interleukin-2 (IL-2) producing cells, within all T cell subsets. The hAME also diminished the frequency of IL-17 and IL-9 producing T cells. The pattern of inhibition varied between CD4+ and CD8+ T cells, between T cell subsets, and depending on the cytokine under study. The hAME also produced a decrease in mRNA expression of granzime B, perforin and activating receptor NKG2D by CD8+ T cells, γδ T cells as well as an upregulation of Foxp3 and IL-10 gene expression in CD4+ T cells and an upregulation of IL-10 mRNA expression in Treg cells. These results show that the hAME differentially regulates different T cell subsets and therefore the effect of the hAME over T cells responses will depend on the T cell subpopulations involved. Still, the hAME has an overall antiinflammatory action.
publishDate 2015
dc.date.none.fl_str_mv 2015-11-26T00:00:00Z
2015-11-26
2017-11-19T14:00:00Z
2018-07-20T14:00:53Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/15498
url http://hdl.handle.net/10773/15498
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de Aveiro
publisher.none.fl_str_mv Universidade de Aveiro
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137558125346816